InMed Completes 1-for-10 Share Consolidation and Changes Name

InMed completed a 1-for-10 share consolidation, reducing shares outstanding from 5,493,735 to approximately 549,374. The company legally changed its name to Mentari Therapeutics, Inc.; the merger closing remains subject to conditions.